| Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma P Bavi, S Uddin, M Ahmed, Z Jehan, R Bu, J Abubaker, M Sultana, ... The American journal of pathology 178 (5), 2109-2120, 2011 | 71 | 2011 |
| Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer S Beg, AK Siraj, S Prabhakaran, Z Jehan, D Ajarim, F Al-Dayel, A Tulbah, ... Breast Cancer Research and Treatment 151, 541-553, 2015 | 54 | 2015 |
| A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma AK Siraj, R Bu, S Prabhakaran, P Bavi, S Beg, M Al Hazmi, M Al-Rasheed, ... Molecular Cancer 13, 1-9, 2014 | 49 | 2014 |
| ALK alteration is a frequent event in aggressive breast cancers AK Siraj, S Beg, Z Jehan, S Prabhakaran, M Ahmed, A R. Hussain, ... Breast Cancer Research 17, 1-12, 2015 | 46 | 2015 |
| Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer AK Siraj, S Prabhakaran, P Bavi, R Bu, S Beg, MA Hazmi, M Al‐Rasheed, ... Cancer 121 (11), 1762-1771, 2015 | 42 | 2015 |
| ALK gene amplification is associated with poor prognosis in colorectal carcinoma P Bavi, Z Jehan, R Bu, S Prabhakaran, N Al-Sanea, F Al-Dayel, ... British journal of cancer 109 (10), 2735-2743, 2013 | 42 | 2013 |
| Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations P Bavi, SE Prabhakaran, J Abubaker, Z Qadri, T George, N Al-Sanea, ... Molecular cancer 9, 1-13, 2010 | 33 | 2010 |
| Molecular markers and pathway analysis of colorectal carcinoma in the Middle East S Beg, AK Siraj, S Prabhakaran, R Bu, M Al‐Rasheed, M Sultana, Z Qadri, ... Cancer 121 (21), 3799-3808, 2015 | 27 | 2015 |
| The potential utility of GATA binding protein 3 for diagnosis of malignant pleural mesotheliomas S Prabhakaran, A Hocking, C Kim, M Hussey, S Klebe Human Pathology 105, 1-8, 2020 | 24 | 2020 |
| Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer C Martini, JM Logan, A Sorvina, C Gordon, AR Beck, BSY Ung, ... Pathology 55 (1), 40-51, 2023 | 13 | 2023 |
| Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data S Klebe, S Prabhakaran, A Hocking, E Pulford, S Moore, M Nicola, ... Pathology 50 (6), 629-634, 2018 | 12 | 2018 |
| The effect of aquaporin 1-inhibition on vasculogenic mimicry in malignant mesothelioma E Pulford, J McEvoy, A Hocking, S Prabhakaran, K Griggs, S Klebe International Journal of Molecular Sciences 18 (11), 2293, 2017 | 11 | 2017 |
| The Incidence of Labelling of Non–Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications S Prabhakaran, WLW Woo, G Xing, D Moffat, M Hussey, DW Henderson, ... Applied Immunohistochemistry & Molecular Morphology 28 (6), 471-476, 2020 | 10 | 2020 |
| Pitfalls in cutaneous melanoma diagnosis and the need for new reliable markers GT Lam, S Prabhakaran, A Sorvina, C Martini, BSY Ung, L Karageorgos, ... Molecular Diagnosis & Therapy 27 (1), 49-60, 2023 | 8 | 2023 |
| Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1 JM Logan, AM Hopkins, C Martini, A Sorvina, P Tewari, S Prabhakaran, ... Cancers 15 (12), 3215, 2023 | 7 | 2023 |
| The role of HER2 overexpression in Middle Eastern papillary thyroid cancer AK Siraj, S Beg, Z Jehan, S Prabhakaran, SS Al-Sobhi, M Al-Dawish, ... Translational Cancer Research 6 (2), 366-373, 2017 | 6 | 2017 |
| Molecular characterization of testicular mesothelioma and the role of asbestos as a causative factor AJ Hocking, EM Thomas, S Prabhakaran, A Jolley, SL Woods, ... Archives of pathology & laboratory medicine 147 (12), 1446-1450, 2023 | 4 | 2023 |
| Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread A Sorvina, C Martini, S Prabhakaran, JM Logan, BSY Ung, C Moore, ... Pathology 55 (6), 792-799, 2023 | 3 | 2023 |
| Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study PA Russell, AL Farrall, S Prabhakaran, K Asadi, W Barrett, C Cooper, ... Pathology 55 (7), 922-928, 2023 | 2 | 2023 |
| Insights into Melanoma Clinical Practice: A Perspective for Future Research GT Lam, C Martini, T Brooks, S Prabhakaran, AM Hopkins, BSY Ung, ... Cancers 15 (18), 4631, 2023 | 2 | 2023 |
